companydata.dkNovo Nordisk Foundation Cellerator P/S: Financial statements 2025
CVR: 44450569
Novo Nordisk Foundation Cellerator P/S (CVR 44450569) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,903,000 and a net result of DKK -13,054,000. Equity amounted to DKK 346,460,000. The solvency ratio was 88.3%. The company had 15 employees in the financial year.
- Gross Profit
- 3,903,000 kr.
- Profit/Loss
- -13,054,000 kr.
- Equity
- 346,460,000 kr.
- Total Assets
- 392,344,000 kr.
- Employees
- 15
Find more companies like Novo Nordisk Foundation Cellerator P/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of December 23, 2025, Trine Haastrup has joined the board of directors of Novo Nordisk Foundation Cellerator P/S.
As of December 23, 2025, Søren Nedergaard has left the board of directors of Novo Nordisk Foundation Cellerator P/S.
As of December 23, 2025, Erika Johanna Söderberg Johnsson has left the board of directors of Novo Nordisk Foundation Cellerator P/S.
Novo Nordisk Foundation Cellerator P/S has published its interim report for the period November 23, 2023 – December 31, 2024.
About Novo Nordisk Foundation Cellerator P/S
Novo Nordisk Foundation Cellerator P/S is a Danish company of the type Kommanditaktieselskab/Partnerselskab based in Kongens Lyngby, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Hassing Ronøe Carlsen. The company is owned by NOVO NORDISK FONDEN. In 2025, the company reported a gross profit of DKK 3,903,000 and a net result of DKK -13,054,000. Equity amounted to DKK 346,460,000.